Pharmacokinetics of AGO178 in Participants With Liver Impairment

Clinical trial NCT01531309 · COMPLETED

Trial details

NCT number: NCT01531309
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2011-02-08
Primary completion: 2011-09-02
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.